PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Mood Disorders

Psychiatric Times. Vol. 29 No. 10
Pages: 1  2  3  
Previous Next
WHAT’S NEW IN MOOD AND PSYCHOTIC DISORDERS 

Are Psychiatric Disorders Inflammatory-Based Conditions?

By Joanna K. Soczynska, HBSc, PhD Candidate, Lucia Zhang, HBSc Candidate,
Sidney H. Kennedy, MD, and Roger S. McIntyre, MD | October 8, 2012
Ms Soczynska is a PhD candidate at the Institute of Medical Science, University of Toronto; Ms Zhang is an undergraduate student in the department of pharmacology and toxicology, University of Toronto; Dr Kennedy is Professor of Psychiatry at the University of Toronto; Dr McIntyre is Professor of Psychiatry and Pharmacology, University of Toronto and Head of the Mood Disorders Psychopharmacology Unit, University Health Network. Ms Soczynska has received travel funds from Janssen and is a recipient of the Eli Lilly Fellowship Award. Ms Zhang reports no conflicts of interest concerning the subject matter of this article. Dr Kennedy has received honoraria or grant funding from AstraZeneca, Bristol-Myers Squibb, Clera Inc, GlaxoSmithKline, Eli Lilly, Lundbeck, Pfizer, Servier, and St Jude Medical in the past 3 years. Dr McIntyre reports that he is on the Advi-sory Boards for AstraZeneca, Bristol-Myers Squibb, France Foundation, GlaxoSmithKline, Janssen-Ortho, Eli Lilly, Lundbeck, Merck, Organon, Pfizer, and Shire. He is on the Speakers Bureau for Janssen-Ortho, AstraZeneca, Eli Lilly, Lundbeck, Merck, and Pfizer. He has been a faculty member for CME activities for AstraZeneca, Bristol-Myers Squibb, CME Outfitters, France Foundation, I3 CME, Eli Lilly, Merck, OptumHealth, Pfizer, and Physicians Postgraduate Press. He has received research grants from AstraZeneca, Janssen-Ortho, Eli Lilly, Lundbeck, Pfizer, and Shire.

Figure

Triggers of inflammation in psychiatric disorders

Sickness behavior

The hypothesis that inflammatory cytokines play a role in the pathophysiology of psychiatric disorders stems from the observation that sickness behavior is characterized by signs and symptoms that are common to major depression. Sickness behavior is a nonspecific reaction to inflammation that is mediated by proinflammatory cytokines (eg, interleukin (IL)-1, IL-6, tumor necrosis factor α [TNF-α], and interferon-γ [IFN-γ]) and is characterized by decreased appetite, amotivation, cognitive impairment, and neurovegetative symptoms.

Inflammatory cytokines in psychiatry

During the past 2 decades, numerous studies have documented abnormal inflammatory cytokine concentrations in patients with MDD, bipolar disorder, or schizophrenia.6-9 Most replicated and common to all 3 conditions are elevated concentrations of circulating TNF-α, IL-6, and IL-1β. Preliminary evidence also documents abnormalities in concentrations of proinflammatory cytokines in the cerebrospinal fluid of patients with MDD, bipolar disorder, or schizophrenia.10-12 It has been hypothesized that inflammation in mood disorders may arise from an imbalance between proinflammatory and anti-inflammatory cytokines. This is supported by evidence of increased proinflammatory to anti-inflammatory cytokine ratios in these populations.13-15

There is a pressing need for studies of inflammatory markers in children and adolescents at risk for or in the early stages of a psychiatric disorder. At this point, it is not known if inflammatory cytokine abnormalities are a cause or consequence of the illness. Preliminary evidence suggests that manic but not depressive symptom severity in adolescents with bipolar disorder is significantly associated with high-sensitivity C-reactive protein (CRP) levels, an acute phase reactant that is elevated in response to inflammation, but not with IL-6 levels.16 A preliminary proinflammatory gene expression signature has been reported in offspring of individuals with bipolar disorder, and elevated messenger RNA (mRNA) levels as well as protein expression levels of IL-1β, IL-6, and TNF-α have been reported in the prefrontal cortex of adolescent suicide victims.17,18 Longitudinal studies in children at genetic risk for major psychiatric disorders may aid identification of biomarkers that allow for earlier detection of candidates for prophylactic treatment.

Although the triggers of inflammation in psychiatric disorders are unknown, they are likely multifactorial in origin and encompass environmental and genetic factors (Figure). For example, maternal infections as well as maternal stress have been reported to pose a risk for the onset of schizophrenia later in life.19,20 Early childhood stress has also been shown to trigger an inflammatory response and may render individuals more vulnerable to psychiatric disorders.

Among female adolescents at high risk for depression, transition to depression was associated with increases in CRP and IL-6 levels; the magnitude of these changes was greater among females with multiple types of childhood adversity.21 Lower socioeconomic status in early childhood (1 to 2 years of age) has also been associated with elevated circulating IL-6 levels in adulthood.22 Environmental factors during the prenatal period or early childhood may activate the inflammatory response, which in combination with a genetic susceptibility or epigenetic modification, may increase the risk of psychiatric disorders.

Inflammation is highly interconnected with oxidative stress and results in a widespread influence on protein expression and cell survival. Oxidative stress exerts effects on DNA methylation patterns and produces unique epigenetic profiles that may increase vulnerability to psychiatric disorders. For example, decreased IL-6 CpG methylation is associated with elevated serum IL-6 and CRP levels in individuals with lifetime depression.23 Moreover, inflammation and oxidative stress are associated with increased apoptosis and decreased neural and glial plasticity.24 Abnormalities in these processes have also been reported in persons with MDD, bipolar disorder, and schizophrenia.25-27

Pages: 1  2  3  
Previous Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Noel fernando | October 19, 2012 10:30 PM EDT

Very interesting article. I recall that this idea was considered in 1970's, so will this be the ultimate answer to good out comes to the mentally ill with Schizophrenia and mood disorders?






 
RELATED TOPICS
Bipolar I disorder
Bipolar II disorder
Mania
Mood disorders
Psychotic affective disorders


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
CME
Advances in Psychiatric Medicine: Differential Diagnosis of Bipolar Disorder Subtypes: Indications for Adjunctive Therapies
Distinguishing Features of Borderline Personality Disorder and Bipolar Disorder—Clinical Diagnosis and Treatment
The State of the Evidence on Pediatric Bipolar Disorder


 
SEARCH MEDICA

Find peer-reviewed literature and websites for practicing medical professionals

CME on Mood Disorders
Evidence on Mood Disorders
Guidelines on Mood Disorders
Patient Education on Mood Disorders
Clinical Trials on Mood Disorders
Practical Articles on Mood Disorders
Research and Reviews on Mood Disorders
All "Mood Disorders" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy